Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.21 (
beta-glucosidase
)
3,280
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The introduction of several kinds of genes into the yeast chromosome is a powerful tool in many fields from fundamental study to industrial application. Here, we describe a general strategy for one-step gene integration and a marker recycling method. Forty base pairs of a short sequence derived from a region adjacent to the
HIS3
locus were placed between cell surface displaying
beta-glucosidase
(
BGL
) and URA3 marker genes.
HIS3
deletion and
BGL
-URA3 fragment integration were achieved via a PCR fragment consisting of the
BGL
-URA3 fragment attached to homology sequences flanked by the
HIS3
targeting locus. The obtained his3::URA3 disruptants were plated on a 5-FOA plate to select for the URA3 deletion due to repeated sequences at both sides of URA3 gene. In all selected colonies,
BGL
genes were integrated at the targeted
HIS3
locus and URA3 was completely deleted. In addition, introduced
BGL
was efficiently expressed, and the transformants fermented cellobiose to ethanol effectively. As our strategy creates next transformation markers continuously together with gene integration, this method can serve as a simple and powerful tool for multiple genetic manipulations in yeast engineering.
...
PMID:Marker-disruptive gene integration and URA3 recycling for multiple gene manipulation in Saccharomyces cerevisiae. 1945 22